Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Olumiant (baricitinib)
Pharma
Pfizer's Litfulo boasts an alopecia edge over Lilly's Olumiant
The FDA gave a green light last week to Pfizer’s once daily oral drug Litfulo in adults and children ages 12 and over with severe alopecia areata.
Fraiser Kansteiner
Jun 26, 2023 9:30am
NICE advises against Merck's Lagevrio, AZ's Evusheld, 3 others
Nov 16, 2022 10:43am
EMA cracks down on JAK drugs with new limitations
Oct 28, 2022 10:20am
Illuminated blue buildings bring attention to alopecia areata
Sep 7, 2022 7:40am
Eli Lilly's Olumiant is first FDA-approved alopecia treatment
Jun 13, 2022 5:54pm
In flurry of activity, EMA issues nods for Sanofi, Lilly drugs
May 20, 2022 10:46am